Three New Cancer Projects Receive Funding in Joint Collaboration Between Oden Institute, MD Anderson's IDSO and TACC
The University of Texas MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences, and the Texas Advanced Computing Center (TACC) at The University of Texas at Austin have announced funding for three cancer research projects as part of the Joint Center for Computational Oncology (JCCO).
This collaborative initiative continues to accelerate breakthroughs in oncology by combining the Oden Institute’...
MD Anderson and HealthEx announce collaboration to develop new platform to give patients direct control of data access
The University of Texas MD Anderson Cancer Center and HealthEx today announced a strategic collaboration aimed at developing tools for...
AACR: HER2 targeted therapy shows promise in previously treated lung cancers
Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer.
...
...
MD Anderson researchers develop novel antibody-toxin conjugate
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to preclinical results published today in Nature Cancer, the new approach combined the benefits of more well-known antibody-drug conjugates (ADCs) with those of immunotherapies.
ADCs have emerged as a breakthrough in recent years due to their...
MD Anderson, the Oden Institute and TACC announce funding for six new collaborative cancer projects
The University of Texas MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences and the Texas Advanced Computing...
Funda Meric-Bernstam, M.D., elected to National Academy of Medicine
Funda Meric-Bernstam, M.D., chair of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center, has been elected...
MD Anderson Research Highlights Special Edition: ASTRO 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
Allison Institute and Institute for Data Science in Oncology blend spatial biology efforts by appointing new member
The James P. Allison Institute™ and the Institute for Data Science in Oncology (IDSO) at The University of Texas MD Anderson Cancer...
ESMO: Novel ADC AZD8205 demonstrates manageable safety profile and preliminary efficacy in first-in-human trial
ABSTRACT: 606O
BARCELONA, Spain – The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety...
MD Anderson and Rice launch initiative to advance cancer-focused operations research
The University of Texas MD Anderson Cancer Center and Rice University today announced the launch of the Center for Operations Research in...